Head of Phase IV and RWE Studies
Merck Healthcare KGaA
Summary
The Head of Global Phase IV and Real World Evidence studies will lead the global strategy and operating model for corporate sponsored Phase IV and other post-approval studies, Real-World Evidence (RWE) generation, and associated business processes. The role ensures that evidence activities are scientifically meaningful, patient- and stakeholder-relevant, operationally feasible, and conducted in accordance with applicable laws, regulations, ethical standards, and company requirements.
Job description
Your Role
The Head of Global Phase IV and Real World Evidence studies will lead the global strategy and operating model for corporate sponsored Phase IV and other post-approval studies, Real-World Evidence (RWE) generation, and associated business processes. The role ensures that evidence activities are scientifically meaningful, patient- and stakeholder-relevant, operationally feasible, and conducted in accordance with applicable laws, regulations, ethical standards, and company requirements.
As the global Business Process Owner (BPO), the role sets and maintains an effective end-to-end process for corporate PhIV and RWE—from evidence need identification and study concept development through execution, oversight, reporting, and evidence dissemination. The role drives consistency and continuous improvement while enabling appropriate adaptation to therapeutic-area and local-market needs.
The Head of Global PhIV and RWE studies is responsible for leading a high-performing team of Clinical Research Managers, Clinical Trial Coordinators, and Subject Matter Experts (SMEs), to deliver global, regional and Local Phase IV and Real Word Evidence Studies – including Interventional, and Non Interventional Studies, and RWE/Epidemiology studies. This leader drives operational excellence and ensures the highest standards of quality and compliance across a focused, study portfolio.
Job specific Competencies & Skills
- Ability to lead and manage teams remotely, in a multicultural environment
- Outstanding leadership skills to ensure high level of standardization and excellence to drive multiple interfaces across geographies
- Able to lead, mentor and manage teams and to direct, influence and motivate people
- Demonstrate excellent organization ability, time management, prioritization, able to handle and oversee multiple tasks simultaneously
- Strong communication skills - verbal, written and listening, both in native language and English
- Demonstrated solid interpersonal skills and strong cultural awareness
- Excellent strategic thinker with the ability to influence others and negotiate effectively
- Adapt well to changes; adapts behavior or work methods in response to new information, changing conditions or unexpected obstacles
- Ability to make risk-based decisions based on a robust benefit/risk assessment
- Enable a culture of continuous improvements to drive efficiency through process improvement, people skills and shared learning
- Position may require domestic/international travel up to 20% of time
Who You Are
Minimum Qualifications
- Graduate degree in life sciences (e.g., Biology, Chemistry, Pharmaceuticals, Medicine)
- Minimum 15 years of relevant experience in drug development or clinical trial management within the pharmaceutical and/or CRO industry
- At least 5 years of team management experience, ideally in a multifunctional and multinational setting
- Comprehensive expertise in drug development with deep knowledge of cross-functional interfaces
- Experience in post marketing, local regional interventional and non-interventional PHIV study types, including RWE/Epidemiology studies
Preferred Qualifications
Advanced degree (MSc, PhD, PharmD, or MD).
Requirements
- Graduate degree in life sciences (e.g., Biology, Chemistry, Pharmaceuticals, Medicine)
- Minimum 15 years of relevant experience in drug development or clinical trial management within the pharmaceutical and/or CRO industry
- At least 5 years of team management experience, ideally in a multifunctional and multinational setting
- Comprehensive expertise in drug development with deep knowledge of cross-functional interfaces
- Experience in post marketing, local regional interventional and non-interventional PHIV study types, including RWE/Epidemiology studies
- Ability to lead and manage teams remotely, in a multicultural environment
- Outstanding leadership skills to ensure high level of standardization and excellence
- Able to lead, mentor and manage teams and to direct, influence and motivate people
- Excellent organization ability, time management, prioritization
- Strong communication skills - verbal, written and listening, both in native language and English
- Solid interpersonal skills and strong cultural awareness
- Excellent strategic thinker with the ability to influence others and negotiate effectively
- Adapt well to changes
- Ability to make risk-based decisions based on a robust benefit/risk assessment
- Enable a culture of continuous improvements through process improvement
- Advanced degree (MSc, PhD, PharmD, or MD) preferred
Benefits
- Health Insurance
- Paid Time Off (PTO)
- Retirement Contributions
- Performance-Based Bonuses
Company overview
Merck Healthcare KGaA is the healthcare business sector of the Merck Group, a German multinational science and technology company headquartered in Darmstadt. Founded in 1668, Merck is the world's oldest operating pharmaceutical and chemical company. The Healthcare division focuses on developing innovative therapies across multiple therapeutic areas including oncology, neurology & immunology, fertility, and cardiovascular, metabolic, and endocrinological disorders. With approximately 62,557 employees globally, Merck Healthcare operates in more than 65 countries and generated 40% of the Group's sales in 2024. The company's oncology portfolio includes blockbuster products like Erbitux (cetuximab) for colorectal and head and neck cancers, Bavencio (avelumab) for urothelial carcinoma, and Tepmetko (tepotinib) for MET-altered cancers. In neurology, Mavenclad (cladribine) has achieved blockbuster status for treating relapsing multiple sclerosis, while the fertility division has helped bring over 6 million babies into the world through products like Gonal-f. Merck Healthcare combines a strong established business with specialty innovation, delivering a diversified portfolio of therapies to millions of patients worldwide.